Cargando…

Molecular diagnosis of ABMR with or without donor‐specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes

We studied the clinical, histologic, and molecular features distinguishing DSA‐negative from DSA‐positive molecularly defined antibody‐mediated rejection (mABMR). We analyzed mABMR biopsies with available DSA assessments from the INTERCOMEX study: 148 DSA‐negative versus 248 DSA‐positive, compared w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halloran, Philip F., Madill‐Thomsen, Katelynn S., Pon, Shane, Sikosana, Majid L. N., Böhmig, Georg A., Bromberg, Jonathan, Einecke, Gunilla, Eskandary, Farsad, Gupta, Gaurav, Hidalgo, Luis G., Myslak, Marek, Viklicky, Ondrej, Perkowska‐Ptasinska, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540308/ https://www.ncbi.nlm.nih.gov/pubmed/35575435 http://dx.doi.org/10.1111/ajt.17092

Ejemplares similares

Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI
por: Halloran, Philip F., et al.
Publicado: (2022)

Relating Molecular T Cell–mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis
por: Madill-Thomsen, Katelynn S., et al.
Publicado: (2023)

Renal allograft DARCness in subclinical acute and chronic active ABMR
por: Kläger, Johannes, et al.
Publicado: (2021)

The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019)

ABMR experiments at ISOLDE
por: Ekström, C, et al.
Publicado: (1982)

ABO-Incompatibility: Time to Challenge the Paradigm of Equivalence in Live-Donor Kidney Transplantation?
por: Eskandary, Farsad, et al.
Publicado: (2022)

Author Correction: Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts
por: Hruba, Petra, et al.
Publicado: (2021)

Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts
por: Hruba, Petra, et al.
Publicado: (2020)

Application of on-line ABMR techniques to nuclides far from stability
por: Ekström, C
Publicado: (1981)

High-activity Classical and Alternative Complement Pathway Genotypes—Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival
por: Mező, Blanka, et al.
Publicado: (2020)

Hyperfine structure of some gold isotopes determined by on-line ABMR techniques
por: Ekström, C, et al.
Publicado: (1979)

Letter of interest: hyperfine structure measurements at sin using ABMR techniques
por: Ekström, C, et al.
Publicado: (1980)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Precision hfs of $^{126}$Cs(T$_{1/2}$=1.63m) by ABMR
por: Pinard, J, et al.
Publicado: (2003)

Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
por: Halloran, Philip F., et al.
Publicado: (2023)

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
por: Mayer, Katharina A., et al.
Publicado: (2022)

Editorial: Advances in the diagnosis and treatment in kidney transplantation
por: Eller, Kathrin, et al.
Publicado: (2022)

Comparative Analysis of Determinants and Outcome of Early and Late Acute Antibody Mediated Rejection (ABMR)
por: Karthikeyan, Balasubramanian, et al.
Publicado: (2023)

A160 MOLECULAR ANALYSIS OF THE INJURY-REPAIR RESPONSE IN ULCERATIVE COLITIS REVEALS HETEROGENEITY IN DISEASE ACTIVIT
por: Madill-Thomsen, K, et al.
Publicado: (2022)

A57 ULCERATIVE COLITIS DISEASE ACTIVITY IS DOMINATED BY INNATE IMMUNITY AND FEATURES OF TISSUE REMODELING
por: Madill-Thomsen, K, et al.
Publicado: (2022)

Utility of Donor-Derived Cell-Free DNA in Detecting ABMR in Patients With AT1R Antibodies
por: Kant, Sam, et al.
Publicado: (2021)

An atomic-beam magnetic resonance (ABMR) system for on-line hyperfine structure measurements in short-lived nuclides
por: Ekström, C, et al.
Publicado: (1978)

Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetes
por: Küssel, Lorenz, et al.
Publicado: (2017)

A atomic-beam magnetic resonance (ABMR) system for on-line hyperfine structure measurements in short-lived nuclides
por: Ekström, C, et al.
Publicado: (1978)

Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome
por: Vietzen, Hannes, et al.
Publicado: (2022)

Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
por: Eskandary, Farsad, et al.
Publicado: (2014)

Magnetic Resonance Imaging for Evaluation of Interstitial Fibrosis in Kidney Allografts
por: Beck-Tölly, Andrea, et al.
Publicado: (2020)

Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial
por: Mühlbacher, Jakob, et al.
Publicado: (2017)

Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
por: Mühlbacher, Jakob, et al.
Publicado: (2020)

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
por: Eskandary, Farsad, et al.
Publicado: (2019)

Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination—A Non-randomized, Controlled Pilot Study
por: Regele, Florina, et al.
Publicado: (2022)

Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—A prospective observational trial
por: Doberer, Konstantin, et al.
Publicado: (2020)

Small RNA Mcr11 requires the transcription factor AbmR for stable expression and regulates genes involved in the central metabolism of Mycobacterium tuberculosis
por: Girardin, Roxie C., et al.
Publicado: (2019)

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
por: Kovarik, Johannes J., et al.
Publicado: (2019)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
por: Mayer, Katharina A., et al.
Publicado: (2022)

Are we ready to implement non-invasive tests to detect allograft rejection in a daily praxis?
por: Viklicky, Ondrej
Publicado: (2019)

Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation
por: Bertrand, Dominique, et al.
Publicado: (2021)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Predictive Potential of Flow Cytometry Crossmatching in Deceased Donor Kidney Transplant Recipients Subjected to Peritransplant Desensitization
por: Osickova, Klara, et al.
Publicado: (2021)

Transthyretin-related Familial Amyloid Polyneuropathy (TTR-FAP) caused by a very rare, de novo mutation in a Polish patient.
por: Lipowska, Marta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c7r4lndp6o00g8mfslsv09rpc1